
EP 152: From Risk Factor to Treatment Target: The New Era of Cardiometabolic Medicine
2026-02-02
0:00
38:33
In this key episode of Parallax, Dr Ankur Kalra sits down with Prof Naveed Sattar to explore how recent therapeutic breakthroughs are fundamentally reshaping the cardiologist's approach to diabetes management.
Through real-world case discussions, Dr Sattar demonstrates practical decision-making for patients across the spectrum - from pre-diabetes to established CAD with Type 2 diabetes. He addresses the tension between robust evidence and cost barriers that limit widespread implementation, while acknowledging unprecedented patient demand driven by genuine quality of life improvements. The conversation concludes with insights on obesogenic environments and the hope that increased competition will ultimately democratize access to these transformative therapies.
Questions and comments can be sent to "[email protected]" and may be answered by Ankur in the next episode.
Host: @AnkurKalraMD and produced by: @RadcliffeCardio
Parallax is Ranked in the Top 100 Health Science Podcasts (#48) by Million Podcasts.
Fler avsnitt från "Parallax by Ankur Kalra"



Missa inte ett avsnitt av “Parallax by Ankur Kalra” och prenumerera på det i GetPodcast-appen.








